• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

感染人类免疫缺陷病毒女性的宫颈上皮内瘤变的细胞学筛查患病率、危险因素及准确性

Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus.

作者信息

Maiman M, Fruchter R G, Sedlis A, Feldman J, Chen P, Burk R D, Minkoff H

机构信息

Department of Obstetrics and Gynecology, State University of New York-Health Science Center at Brooklyn 11203, USA.

出版信息

Gynecol Oncol. 1998 Mar;68(3):233-9. doi: 10.1006/gyno.1998.4938.

DOI:10.1006/gyno.1998.4938
PMID:9570972
Abstract

OBJECTIVES

The objective was to evaluate the sensitivity and specificity of cervical cytology in women infected with the human immunodeficiency virus (HIV), risk factors for abnormal cytology in HIV-infected and uninfected women, and risk factors for histologic diagnosis of cervical intraepithelial neoplasia (CIN) in HIV-infected women.

METHODS

Methods included a cross-sectional analysis of cervical cytology, colposcopic impression, and histology in 248 HIV-infected women and multivariate analyses of risk factors for abnormal cytology in 253 HIV-infected and 220 uninfected women and risk factors for CIN in 186 HIV-infected women.

RESULTS

The sensitivity and specificity of cytology for all CIN grades were 0.60 and 0.80 and, for high-grade CIN, 0.83 and 0.74. The prevalence of abnormal cytology was 32.9% in HIV-infected and 7.6% in HIV-negative women. Independent risk factors for abnormal cytology were immunodeficiency [odds ratio (OR) 8-17, P < 0.001] and human papillomavirus (HPV) infection (OR = 5, P < 0.001). The prevalence of CIN on histology was 32% in HIV-infected women, and the only independent risk factor for CIN was oncogenic HPV type (OR = 5, P = 0.005).

CONCLUSION

Given the high prevalence of abnormal cytology and CIN in HIV-infected women, cytologic screening has significant limitations. Both immunodeficiency and type of HPV infection are important risk factors.

摘要

目的

评估宫颈细胞学检查对感染人类免疫缺陷病毒(HIV)女性的敏感性和特异性,HIV感染和未感染女性细胞学异常的危险因素,以及HIV感染女性宫颈上皮内瘤变(CIN)组织学诊断的危险因素。

方法

方法包括对248例HIV感染女性的宫颈细胞学、阴道镜印象和组织学进行横断面分析,对253例HIV感染女性和220例未感染女性细胞学异常的危险因素以及186例HIV感染女性CIN的危险因素进行多变量分析。

结果

所有CIN分级的细胞学检查敏感性和特异性分别为0.60和0.80,高级别CIN的敏感性和特异性分别为0.83和0.74。HIV感染女性细胞学异常的患病率为32.9%,HIV阴性女性为7.6%。细胞学异常的独立危险因素为免疫缺陷[比值比(OR)8 - 17,P < 0.001]和人乳头瘤病毒(HPV)感染(OR = 5,P < 0.001)。HIV感染女性CIN的组织学患病率为32%,CIN的唯一独立危险因素是致癌性HPV类型(OR = 5,P = 0.005)。

结论

鉴于HIV感染女性细胞学异常和CIN的高患病率,细胞学筛查有显著局限性。免疫缺陷和HPV感染类型都是重要的危险因素。

相似文献

1
Prevalence, risk factors, and accuracy of cytologic screening for cervical intraepithelial neoplasia in women with the human immunodeficiency virus.感染人类免疫缺陷病毒女性的宫颈上皮内瘤变的细胞学筛查患病率、危险因素及准确性
Gynecol Oncol. 1998 Mar;68(3):233-9. doi: 10.1006/gyno.1998.4938.
2
Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection.HIV 感染妇女的正常宫颈细胞学和无致癌 HPV 感染证据者的宫颈癌前病变和宫颈癌风险。
JAMA. 2012 Jul 25;308(4):362-9. doi: 10.1001/jama.2012.5664.
3
Human papilloma virus correlates of high grade cervical dysplasia in HIV-infected women in Mombasa, Kenya: a cross-sectional analysis.肯尼亚蒙巴萨感染艾滋病毒的女性中高级别宫颈发育不良与人类乳头瘤病毒的相关性:一项横断面分析。
Virol J. 2018 Mar 27;15(1):54. doi: 10.1186/s12985-018-0961-3.
4
Virologic versus cytologic triage of women with equivocal Pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia.巴氏涂片结果不明确的女性的病毒学与细胞学分流:检测高级别上皮内瘤变准确性的荟萃分析
J Natl Cancer Inst. 2004 Feb 18;96(4):280-93. doi: 10.1093/jnci/djh037.
5
Analysis of the prevalence of human papillomavirus and abnormal anal cytology in women at risk.分析高危女性人群中人类乳头瘤病毒感染和异常肛门细胞学的流行情况。
J Obstet Gynaecol. 2021 Oct;41(7):1139-1144. doi: 10.1080/01443615.2020.1845630. Epub 2021 Jan 16.
6
Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus: prevalence, risk factors, and validity of Papanicolaou smears. New York Cervical Disease Study.感染人类免疫缺陷病毒的女性的宫颈上皮内瘤变:患病率、危险因素及巴氏涂片检查的有效性。纽约宫颈疾病研究。
Obstet Gynecol. 1994 Oct;84(4):591-7.
7
Risk of High-Grade Cervical Lesions in Atypical Squamous Cells of Undetermined Significance (ASC-US) Cytology: Comparison between HIV-Infected and HIV-Negative Women.高危型宫颈病变在意义不明确的非典型鳞状细胞(ASC-US)细胞学中的风险:HIV 感染与 HIV 阴性妇女的比较。
Asian Pac J Cancer Prev. 2021 Feb 1;22(2):547-551. doi: 10.31557/APJCP.2021.22.2.547.
8
Discrepant HPV/cytology cotesting results: Are there differences between cytology-negative versus HPV-negative cervical intraepithelial neoplasia?人乳头瘤病毒(HPV)/细胞学联合检测结果不一致:细胞学阴性与HPV阴性的宫颈上皮内瘤变之间是否存在差异?
Cancer Cytopathol. 2017 Oct;125(10):795-805. doi: 10.1002/cncy.21905. Epub 2017 Aug 17.
9
Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less.阴道镜诊断为1级及以下宫颈上皮内瘤变(CIN)后,发生CIN 3级或癌症的后续风险及表现。
Am J Obstet Gynecol. 2006 Nov;195(5):1260-5. doi: 10.1016/j.ajog.2006.07.036.
10
High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.高危型人乳头瘤病毒16型(HPV-16)DNA的高水平与有感染人类免疫缺陷病毒(HIV)风险或已感染HIV的女性的高级别宫颈病变相关。
AIDS. 2005 May 20;19(8):785-94. doi: 10.1097/01.aids.0000168972.65304.6b.

引用本文的文献

1
Digital cervicography using mobile phones with real-time consultation (DCRC) to improve performance of Visual Inspection with Acetic Acid (VIA) in cervical cancer screening of HIV-infected women. A cross-sectional study.使用手机进行实时会诊的数字宫颈摄影术(DCRC)以提高艾滋病毒感染女性宫颈癌筛查中醋酸肉眼观察法(VIA)的性能。一项横断面研究。
Gynecol Oncol Rep. 2024 Dec 20;57:101661. doi: 10.1016/j.gore.2024.101661. eCollection 2025 Feb.
2
Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis.人类免疫缺陷病毒(HIV)感染者中,宫颈癌筛查策略对高级别宫颈上皮内瘤变(CIN2+/CIN3+)的诊断准确性:一项系统评价和荟萃分析。
EClinicalMedicine. 2022 Sep 27;53:101645. doi: 10.1016/j.eclinm.2022.101645. eCollection 2022 Nov.
3
The interplay of HIV and human papillomavirus-related cancers in sub-Saharan Africa: scoping review.撒哈拉以南非洲地区 HIV 和人乳头瘤病毒相关癌症的相互作用:范围综述。
Syst Rev. 2020 Apr 22;9(1):88. doi: 10.1186/s13643-020-01354-1.
4
Performance of OncoE6 Cervical Test in detecting cervical precancer lesions in HIV-positive women attending an HIV clinic in Bujumbura, Burundi: a cross-sectional study.布隆迪布琼布拉一家艾滋病诊所中,OncoE6宫颈检测在检测HIV阳性女性宫颈癌前病变中的表现:一项横断面研究。
BMJ Open. 2019 Sep 6;9(9):e029088. doi: 10.1136/bmjopen-2019-029088.
5
Detection and Concentration of Plasma Aflatoxin is Associated with Detection of Oncogenic Human Papillomavirus in Kenyan Women.肯尼亚女性血浆中黄曲霉毒素的检测与浓度测定与致癌性人乳头瘤病毒的检测相关。
Open Forum Infect Dis. 2019 Sep 2;6(9). doi: 10.1093/ofid/ofz354.
6
A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.肯尼亚人免疫缺陷病毒感染和未感染妇女中与致癌性人乳头瘤病毒检测相关因素的横断面分析。
BMC Infect Dis. 2019 Apr 27;19(1):352. doi: 10.1186/s12879-019-3982-7.
7
Hybrid capture as a tool for cervical lesions screening in HIV-infected women: insights from a Brazilian cohort.杂交捕获法作为HIV感染女性宫颈病变筛查工具:来自巴西队列的见解。
Braz J Infect Dis. 2018 Jan-Feb;22(1):16-23. doi: 10.1016/j.bjid.2017.10.007. Epub 2017 Dec 6.
8
Cervical and anal HPV infection: cytological and histological abnormalities in HIV-infected women in Thailand.人乳头瘤病毒(HPV)感染的宫颈和肛门:泰国 HIV 感染女性的细胞学和组织学异常。
J Virus Erad. 2015 Apr 1;1(2):96-102. doi: 10.1016/S2055-6640(20)30485-4.
9
Comparison of Pap Smear and Colposcopy in Screening for Cervical Cancer in Patients with Secondary Immunodeficiency.巴氏涂片与阴道镜检查在继发性免疫缺陷患者宫颈癌筛查中的比较
Electron Physician. 2015 Nov 20;7(7):1542-8. doi: 10.19082/1542. eCollection 2015 Nov.
10
An Insight Into Cervical Cancer Screening and Treatment Capacity in Sub Saharan Africa.深入了解撒哈拉以南非洲地区的宫颈癌筛查与治疗能力
J Low Genit Tract Dis. 2016 Jan;20(1):31-7. doi: 10.1097/LGT.0000000000000165.